NICE guidance on pazopanib for first-line treatment of advanced renal-cell carcinoma

被引：4
|
作者：
Griffiths, Christian [1 ]
Hay, Nicola [1 ]
Sutcliffe, Frances [1 ]
Stevens, Andrew [1 ]
机构：
[1] Natl Inst Hlth & Clin Excellence, Manchester, Lancs, England
来源：
LANCET ONCOLOGY | 2011年 / 12卷 / 03期
关键词：
INTERFERON ALPHA-2A; RANDOMIZED-TRIAL; MEDROXYPROGESTERONE; VINBLASTINE;
D O I：
10.1016/S1470-2045(11)70042-0
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：221 / 222
页数：2
相关论文
共 50 条
  • [21] 10 year outcomes from a single-centre experience of sunitinib and pazopanib as first-line treatment of metastatic renal-cell carcinoma (mRCC).
    Chow, Shien
    Pillai, Manon Rhys
    Galvis, Victoria
    Leach, Rebecca
    Keene, Elizabeth
    Chan, Kevin
    Spencer-Shaw, Andrea
    Thistlethwaithe, Fiona
    Hawkins, Robert E.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [22] First-line pazopanib in patients with advanced non-clear cell renal carcinoma: An Italian case series
    Buti, Sebastiano
    Bersanelli, Melissa
    Massari, Francesco
    De Giorgi, Ugo
    Caffo, Orazio
    Aurilio, Gaetano
    Basso, Umberto
    Carteni, Giacomo
    Caserta, Claudia
    Galli, Luca
    Boccardo, Francesco
    Procopio, Giuseppe
    Facchini, Gaetano
    Fornarini, Giuseppe
    Berruti, Alfredo
    Fea, Elena
    Naglieri, Emanuele
    Petrelli, Fausto
    Iacovelli, Roberto
    Porta, Camillo
    Mosca, Alessandra
    WORLD JOURNAL OF CLINICAL ONCOLOGY, 2021, 12 (11): : 1037 - 1046
  • [23] Initial experience with first-line pazopanib in the treatment of metastatic renal cell carcinoma: A single institution data
    Joshi, A.
    Agarwala, V
    Ramaswamy, A.
    Noronha, V
    Patil, V. M.
    Menon, S.
    Popat, P.
    Sable, N.
    Prabhash, K.
    INDIAN JOURNAL OF CANCER, 2016, 53 (04) : 575 - 578
  • [24] Pazopanib in the treatment of advanced renal cell carcinoma
    Cella, David
    Beaumont, Jennifer L.
    THERAPEUTIC ADVANCES IN UROLOGY, 2016, 8 (01) : 61 - 69
  • [25] Optimal First-Line Treatment of Metastatic Renal-Cell Carcinoma: A Network Meta-Analysis
    Hahn, Andrew W.
    Hale, Peter
    Maughan, Benjamin L.
    Haaland, Benjamin
    Agarwal, Neeraj
    KIDNEY CANCER, 2018, 2 (02) : 115 - 121
  • [26] Cost-effectiveness of nivolumab plus ipilimumab as first-line therapy in advanced renal-cell carcinoma
    Wu, Bin
    Zhang, Qiang
    Sun, Jie
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2018, 6
  • [27] First-line treatment of metastatic renal cell carcinoma
    Bruchbacher, Andreas
    Netsch, Christopher
    Gross, Andreas J. J.
    UROLOGIE, 2023, 62 (08): : 830 - 839
  • [28] First-line treatment ofmetastatic renal cell carcinoma
    Bruchbacher, Andreas
    Netsch, Christopher
    Gross, Andreas J.
    ONKOLOGIE, 2024, 30 (04): : 319 - 328
  • [29] Broad immunomodulating effect of first-line Pazopanib in metastatic renal cell carcinoma patients
    Verzoni, E.
    Cova, A.
    Squarcina, P.
    De Cecco, L.
    Rinchai, D.
    Bedognetti, D.
    Grassi, P.
    Ratta, R.
    Procopio, G.
    Rivoltini, L.
    ANNALS OF ONCOLOGY, 2017, 28
  • [30] Broad immunomodulating effect of first-line pazopanib in metastatic renal cell carcinoma patients
    Verzoni, E.
    De Cecco, L.
    Dugo, M.
    Rinchai, D.
    Bedognetti, D.
    Grassi, P.
    Ratta, R.
    Cova, A.
    Squarcina, P.
    Huber, V.
    Montone, R.
    Sorrentino, M.
    Procopio, G.
    Rivoltini, L.
    ANNALS OF ONCOLOGY, 2017, 28
12345